Population pharmacokinetics of halofantrine in healthy volunteers and patients with symptomatic falciparum malaria
Aims To investigate the population pharmacokinetics of the antimalarial halofantrine (HF) in healthy volunteers and patients with symptomatic falciparum malaria. Methods Healthy volunteer data were obtained from six volunteers who received three different doses of HF (250, 500 and 1000 mg) after an...
Κύριοι συγγραφείς: | Klein, K, Aarons, L, Ter Kuile, F, Nosten, F, White, N, Edstein, MD, Teja-Isavadharm, P |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2012
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Population pharmacokinetics of halofantrine in healthy volunteers and patients with symptomatic falciparum malaria.
ανά: Klein, K, κ.ά.
Έκδοση: (2012) -
Pharmacokinetics, efficacy and toxicity of parenteral halofantrine in uncomplicated malaria.
ανά: Krishna, S, κ.ά.
Έκδοση: (1993) -
Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria.
ανά: ter Kuile, F, κ.ά.
Έκδοση: (1993) -
Comparison of capillary whole blood, venous whole blood, and plasma concentrations of mefloquine, halofantrine, and desbutyl-halofantrine measured by high-performance liquid chromatography.
ανά: Ter Kuile, F, κ.ά.
Έκδοση: (1994) -
Population pharmacokinetics of mefloquine in patients with acute falciparum malaria.
ανά: Simpson, J, κ.ά.
Έκδοση: (1999)